Blueberries Financial Statements From 2010 to 2024

BBRRF Stock  USD 0.01  0.0004  3.85%   
Blueberries Medical financial statements provide useful quarterly and yearly information to potential Blueberries Medical Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Blueberries Medical financial statements helps investors assess Blueberries Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Blueberries Medical's valuation are summarized below:
Blueberries Medical Corp does not presently have any fundamental signals for analysis.
Check Blueberries Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Blueberries Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Blueberries financial statements analysis is a perfect complement when working with Blueberries Medical Valuation or Volatility modules.
  
This module can also supplement various Blueberries Medical Technical models . Check out the analysis of Blueberries Medical Correlation against competitors.

Blueberries Medical Corp OTC Stock Current Valuation Analysis

Blueberries Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Blueberries Medical Current Valuation

    
  3.89 M  
Most of Blueberries Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Blueberries Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Blueberries Medical Corp has a Current Valuation of 3.89 M. This is 99.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.98% higher than that of the company.

Blueberries Medical Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Blueberries Medical's current stock value. Our valuation model uses many indicators to compare Blueberries Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Blueberries Medical competition to find correlations between indicators driving Blueberries Medical's intrinsic value. More Info.
Blueberries Medical Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Blueberries Medical's earnings, one of the primary drivers of an investment's value.

About Blueberries Medical Financial Statements

Blueberries Medical stakeholders use historical fundamental indicators, such as Blueberries Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Blueberries Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Blueberries Medical's assets and liabilities are reflected in the revenues and expenses on Blueberries Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Blueberries Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. BLUEBERRIES MEDICAL is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Blueberries OTC Stock

Blueberries Medical financial ratios help investors to determine whether Blueberries OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Blueberries with respect to the benefits of owning Blueberries Medical security.